AI summary Trust: medium Third-party lab

LabE tested this tirzepatide batch (October 2,2025) at 99.9% purity via HPLC. The tested quantity was 46mg against a 40mg label, a 15% deviation. Endotoxin status is unknown. The test is recent (under 3 months). Customers can cross-check on the lab's public verification URL.

Watch out for
  • no endotoxin test
  • quantity deviation (15%)
Test date
2026-03-18
Purity
99.90% 99.90%
Batch / lot
October 2,2025
Lab
LabE
Quantity
label 40mg tested 46mg
Qty vs label
+15.0%
Endotoxins
—
Test score
7.6
Manufacturer
Qing Li Peptide
View vendor dossier
Certificate

Test report image

Certificate scan
Certificate scan as published.
Source

Finnrick

✓ Artifact captured

We have the certificate image (SHA-256 hash captured) — you can verify it loads from the upstream lab and matches the artifact below.

Verify on upstream
Method
HPLC + mass quantification + endotoxins
Test type
finnrick_composite
Dose
40mg
Container
White Label / Silver Crimp / Clear Green Cap
Catalogued
2026-04-17
Artifact hash
850023fc7fff0fbd…
This COA is part of TitrateLab's community-trust corpus. See more from Qing Li Peptide or learn how trust scores are computed on the methodology page.